To make decisions about implementing systematic depression screening, primary care physicians who serve Spanish-speaking populations need to know whether Spanish language depression-screening instruments are accurate. We aimed to review systematically the evidence regarding diagnostic accuracy of depression-screening instruments in Spanish-speaking primary care populations.
INTRODUCTION

D
epression is common and costly, and it causes considerable suffering for patients and their families. Recent advances in clinical detection and treatment of depression led to a 2002 US Preventive Services Task Force (USPSTF) recommendation for depression screening in primary care settings. 1 Despite progress in this area, however, evidence also suggests disparities exist in detection and treatment of depression and other mental health disorders by ethnic and racial minorities. 2, 3 These disparities are particularly apparent in US Latinos, [4] [5] [6] [7] who now constitute the nation's largest minority group.
SPA NISH L A NGU AGE DEPR ES SION SCR EENING
Although legal and economic barriers contribute to these disparities, language and cultural barriers also play an important role. 8 In recent years, the number of US residents who are Spanish speakers has risen dramatically. More than 31 million US residents now speak Spanish at home. 9 Within this changing sociocultural context, those who provide primary care to Spanish-speaking populations must make decisions about implementing systematic depression screening in their clinics and health centers. Among the key pieces of information clinicians and clinical leaders need in order to make these decisions is how the various available depression-screening instruments perform in Spanish-speaking primary care populations.
Despite their large and growing numbers, US Latinos with limited English profi ciency are poorly represented in large clinical studies of depression screening. In a large systematic review and meta-analysis 10 on which current USPSTF recommendations are based, only 6 of the 41 included studies reported enrolling more than 5% Hispanic participants. Moreover, even when Hispanics have been enrolled in trials of depression screening, studies typically exclude non-English speakers, 11, 12 do not report the proportions of enrolled participants who are Spanish speakers, [13] [14] [15] [16] or do not report the diagnostic accuracy of the screening instrument used for Spanish speakers. [17] [18] [19] [20] Because clinical manifestations of mental health disorders are partly dependent upon linguistically and culturally determined conceptions of illness, evidence based mainly on studies in English-speaking populations may not be generalizable to non-English-speaking populations. Language and culture can affect patterns of endorsement of depression scale items and dimensions, even when a well-translated instrument is used. 17, [21] [22] [23] Hence, the accuracy of a depression-screening instrument that is translated from English into Spanish may be different from the accuracy of the original version.
We undertook a systematic review of the literature aimed at summarizing the evidence regarding diagnostic accuracy of depression-screening instruments for Spanish-speaking populations studied in primary care settings.
METHODS
Search Strategy
We searched PubMed for articles through May 28, 2008 , using medical subject headings (MeSH) terms "depressive disorder" or "depression," and combined this result with the MeSH terms "mass screening" and with the terms "Hispanic Americans" (includes Latino) or "Mexican Americans." We then searched the PubMed database using the same publication date range for the MeSH term "Spanish" combined with MeSH terms "screening instrument" or "tool" or "questionnaire" and "depressive disorder" or "depression." We used analogous search strategies to search for additional articles in PsycINFO, CINAHL, and EMBASE. Results from all 3 searches were combined, and duplicate abstracts were eliminated. We supplemented these sources by searching the Cochrane collection database for articles on "depression," "neurosis," and "anxiety disorders," searching further by hand the bibliographies from the articles yielded from the literature search, and searching evidence tables and bibliographies from pertinent reviews of depression screening in primary care. A doctoral-level research librarian assisted with all electronic searching.
Eligibility and Exclusion Criteria
To be eligible, studies had to report data describing the diagnostic accuracy of 1 or more Spanish language versions of depression-screening instruments compared with a reference standard. Acceptable reference standards included either a diagnosis by a mental health professional or a structured diagnostic interview, such as the Structured Clinical Interview for the DSM-IV (SCID), 24 Schedule for Clinical Assessment in Neuropsychiatry (SCAN), 25 or the Composite International Diagnostic Interview (CIDI). 26 The diagnostic standard had to be applied both to screen-positive and screen-negative cases, or a randomly selected subsample thereof. Eligible studies had to provide both the sensitivities and specifi cities of the screening instrument compared with the reference standard, or data that would allow calculation of these values. We included studies that examined the detection of related mood disorders, such as dysthymia, minor (subsyndromal) depression, and anxiety disorders, provided that they also examined the detection of major depression.
Studies had to enroll unselected patients in an outpatient primary care setting, defi ned as family medicine, internal medicine, general practice, pediatrics, geriatrics, and general obstetrics-gynecology, including prenatal and postpartum care. Because we sought evidence generalizable to primary care practice, we excluded studies if they were performed in nonclinical, community-based settings, or in disease-specifi c or referral populations. We excluded studies from inpatient, institutional, or psychiatric settings. As other reviews of depression screening have done, 10, 27 we included studies in primary care settings outside the United States, though we abstracted them into a separate table. We did not limit our search by language. Two authors independently reviewed abstracts of identifi ed articles. Studies were excluded at this stage if both reviewers agreed that eligibility criteria were
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clearly not met. If either reviewer could not exclude the study based on the abstract, the full article was reviewed independently by 2 authors. If these authors were discordant in their assessment, a third author independently reviewed the article, and consensus was reached by discussion among all 3 authors.
Data Abstraction
Data from articles published in English or Spanish were abstracted by 1 author directly into evidence tables. A second author confi rmed the accuracy of the data abstraction. We abstracted sensitivity and specifi city data that corresponded to "standard" (as reported by study authors) cut points. When the standard cut points for a given screening instrument varied between studies, however, we chose a common cut point to allow for comparisons among studies. When needed, we calculated 95% confi dence intervals (CIs) for sensitivity and specifi city using data from the articles. We also abstracted area the under the curve (AUC) as an overall measure of an instrument's diagnostic accuracy, when available.
Quality Appraisal
Studies meeting inclusion criteria were independently rated as good, fair, or poor by 2 authors. Differences were resolved by consensus. We used the QUADAS (a tool for the quality assessment of studies of diagnostic accuracy) checklist 28 to guide the appraisals, and we emphasized independent and blind administration of the screening test and the diagnostic reference standard, as well as the potential for bias in selection of subjects for screening or for administration of the diagnostic assessment.
RESULTS
Of 495 studies identifi ed by the initial electronic and hand searches, we eliminated 447 based on abstract alone ( Figure 1 ). The most common reasons for exclusion at this level were that studies were not conducted in a primary care setting and/or that there was no comparison of a screening instrument against a diagnostic standard. We reviewed the remaining 48 potentially eligible studies in full. Of these, 12 studies met inclusion criteria.
Included studies were heterogeneous with respect to care setting, demographic subpopulations studied, screening instrument used, and quality. Three studies were conducted in the United States: 1 in Puerto Rican outpatients, 29 1 in postpartum women in Texas and Connecticut, 30 and 1 in immigrants from Mexico and Central America attending an urban general medical clinic in California. 31 Nine additional studies conducted in non-US settings met our inclusion criteria. [32] [33] [34] [35] [36] [37] [38] [39] [40] The most common, important methodologic limitation was lack of documentation that administration of the screening test and reference standard were blinded and independent of each other.
Detailed Assessment, US Studies
Details of the US studies assessing depression-screening instruments are displayed in Table 1 . Robison et al 29 determined diagnostic accuracy of 4 different depression-screening instruments: the Yale 1 Question, the 2-item version of the Primary Care Evaluation of Mental Disorders (PRIME-MD-2), both the 30-item and 15-item versions of the Geriatric Depression Scale (GDS), and the Center for Epidemiologic Studies-Depression scale (CES-D, both the 20-item and 10-item versions) in a sample of 303 middle-aged and older Puerto Ricans living in the northeastern United States. They found the 20-item and 10-item versions of the CES-D performed best, with sensitivities of 73% and 76% and specifi cities of 72% and 70%, respectively. These fi gures correspond to a positive likelihood ratio (+LR) of about 2.5 for both of these versions. The 15-item GDS had reasonable sensitivity (76%) but only fair specifi city (64%) for major depression in this population, yielding +LR = 2.0. The 2 ultrashort screening instruments, the Yale 1 Question and the PRIME-MD-2, were sensitive for depression (86% and 92%, respectively) but had poor specifi city (42% and 44%), yielding +LR = 1.5 and 1.6 only.
Beck and Gable assessed diagnostic accuracy of the Spanish version of the Postpartum Depression Screening Scale (PDSS), 30 an instrument they had previously a Although some experts cite cut points of 10 and 5 as standard for the GDS-30 and GDS-15, these investigators reported results for cut points of 9 and 6, respectively, for these 2 instruments. b The authors provided sensitivity and specifi city data only for combined major and minor depression (not for major depression alone). a When sensitivity and specifi city data were presented for multiple cut points, standard cut points (as reported by individual study authors) are presented. Where possible, we also include other cut points as needed to permit between-study comparisons for the same screening instrument. b Depression severity (ie, major vs minor) not specifi ed in article.
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formed nearly as well, having a sensitivity of 78% and specifi city of 85% (+LR = 5.2). Ring et al examined the accuracy of the full 20-item CES-D in 48 Hispanic immigrants at 1 urban outpatient clinic. 31 Using a cut point of 21 of 60, they found it to have a sensitivity of 92% and a specifi city of 74% (+LR = 3.5).
Detailed Assessment, Non-US Studies
Details of the non-US studies assessing depression-screening instruments are displayed in Table 2 . Aguilar-Navarro et al examined the accuracy of the 9-item Mexican Health and Age Study (MHAS) in a sample of 199 geriatric outpatients in Mexico. 32 They found the MHAS to be 81% sensitive and 69% specifi c for "depression." Vega-Dienstmaier et al determined the accuracy of the Spanish language version of the Edinburgh Postnatal Depression Scale (EPDS) in 321 postpartum women in Peru and found a sensitivity of 89% and specifi city of 72% for major postpartum depression. 33 Wulsin et al found the Patient Health Questionnaire depression module (PHQ-9) was 77% sensitive and 100% specifi c for major depression in a sample of Honduran mothers. 34 This study was rated as poor quality, however.
The remaining 6 non-US studies were from Spain. Aragonès Benaiges at al found the Spanish version of the Self-rating Depression Scale (SDS) to be very sensitive (95%) and moderately specifi c (74%) for major depression among 350 Spanish primary care patients. 35 Baca et al found the PRIME-MD-9 was 72% sensitive and 86% specifi c for major depression in a sample of 312 primary care patients in Spain. 38 Fernández-San Martín et al found that the 30-item GDS with a cut point of 9 yielded a sensitivity (87%) and specifi city of (63%) for combined major and minor depression in 192 elderly Spanish primary care patients. 39 Garcia-Esteve et al 36 found that the Spanish version of the EPDS was highly accurate for detecting major depression (86% sensitivity, 95% specifi city) and moderately accurate for detecting both major and minor depression (sensitivity 62%, specifi city 98%) in a sample of 334 Spanish postpartum women. Martinez de la Iglesia et al administered the 15-item GDS to 249 geriatric patients, with a resultant sensitivity of 81% and a specifi city of 77%. 43 Ortega-Orcos assessed the 15-item GDS and found a sensitivity of 82% and specifi city of 98%. 37 A 5-item version was 86% sensitive and 85% specifi c. Table 3 displays information for fi nding the Spanish language versions of the principal screening instruments.
DISCUSSION
Our systematic review found limited evidence that directly guides primary care-based depression screening for Spanish speakers, a large and rapidly growing segment of the US population. Specifi cally, we found fair evidence suggesting that the 20-item and 10-item versions of the CES-D are accurate for depression screening in Spanish speakers seen general primary care settings. Although we found limited evidence from non-US studies suggesting that the PRIME-MD-9 accurately detects depression in Spanish speakers, we did not fi nd studies that provided a direct assessment of diagnostic -accuracy of the original PRIME-MD-9 or its newer relative, the PHQ-9, 11 in US Spanish speakers. This review also summarizes evidence regarding the accuracy of instruments designed specifi cally for screening 2 specifi c Spanish-speaking primary care subpopulations, geriatric outpatients and postpartum women. For geriatric outpatients, we found evidence from both US and non-US studies that the 30-item and 15-item versions of the GDS-Spanish are accurate depression-screening instruments. For postpartum women, we found limited evidence suggesting that the PDSS-Spanish (1 fair quality US study) and probably the EPDS-Spanish (2 fair-good quality studies from Latin American and Europe) are accurate screening tests for postpartum depression. Because Hispanic women in the United States often have better access to primary health care during the perinatal period, 44 postpartum screening represents an opportunity to detect depression in this at-risk population.
To our knowledge this review of the evidence is the fi rst regarding the diagnostic accuracy of depressionscreening instruments in Spanish-speaking primary care populations. By specifi cally addressing the question of diagnostic accuracy of screening instruments for Spanish-speaking Hispanic subpopulations, this study complements and extends fi ndings from other published studies of primary care depression screening in US Latinos, especially those that found the PRIME-MD-9 45 and PHQ-9 16, 17 are generally accurate across racially and ethnically diverse populations which included Latinos. Taken together, these fi ndings suggest that accurate screening instruments are available for use in Spanish-speaking primary-care patients.
Our fi ndings also point to important gaps in our knowledge that should be the subject of further research. Most notably, we found no evidence directly supporting the accuracy of ultrashort screening instruments in Spanish. Given the competing demands faced by primary care clinicians, [46] [47] [48] ultrashort depressionscreening instruments are highly desirable. Unfortunately, the only study we identifi ed that evaluated ultrashort screening instruments in a general primary care setting found that the "anhedonia" item in the PRIME-MD-2 lacked specifi city compared with studies using the original PRIME-MD-2 14 or the newer PHQ-2 in English speakers. 15 This difference could represent true differential item functioning in US Spanish speakers compared with English speakers, an explanation supported by studies suggesting that US Latino patients with similar levels of depression are more likely to endorse anhedonia than non-Hispanic whites. 17, 22 Another contributing factor could be that the original PRIME-MD-2 instrument studied by Robison et al 29 used dichotomous (yes/no) response options to questions about recent depressed mood and anhedonia, whereas the newer version (ie, the PHQ-2) allows 4 graded response options that correspond to the number of days during the past 2 weeks that patients are bothered by these symptoms (not at all, several days, more than one-half the days, or nearly every day). 11 Studies suggest the PHQ, with these graded response options, has better sensitivity and specifi city for depressive disorders than the original PRIME-MD. 11, 15, 45 Whether these improved operating characteristics apply to Spanish-speaking Latinos is unclear, particularly for the ultrashort 2-item instrument.
Subsequent research should assess the accuracy of the Spanish language PHQ-2 and/or other brief, practical screening instruments in Spanish-speaking primary care populations. To be most generalizable to US Hispanic patients, such studies should take place in settings where these patients commonly receive care, such as community health centers. Failure to identify brief, accurate screening instruments for use in US Spanish-speaking populations could result in missed diagnoses and wasted resources.
Our study has limitations. First, despite a vigorous attempt to identify relevant articles, it is possible that some were missed or that publication bias led to underreporting of data related to our question. Second, our ability to make strong recommendations for clinicians is hindered by the limited number and quality of studies, as well as by their heterogeneity in setting, patient demographics (including country of origin), screening instrument used, patient selection methods, and educational and literacy level of participants. Third, because the US Hispanic population is not homogeneous, evidence that a depression-screening instrument is accurate in one subpopulation may not generalize to other subpopulations. 49 Fourth, our focus on identifying direct evidence for accuracy among Spanish-speaking patients in general primary care settings led to the exclusion of high-quality studies that enrolled Latino participants but did not report how many of these participants were Spanish speakers. Finally, we caution that our fi ndings apply only to the question of diagnostic accuracy of depression-screening instruments. They do not address other important issues relevant to decisions about implementing systematic screening of Spanish-speaking populations in a practice or health system (eg, availability of treatment). Benefi ts from depression screening are most likely to accrue when systems are also in place for treatment and follow-up of patients found to be depressed at screening. 1 In summary, we found fair evidence supporting the diagnostic accuracy of Spanish language versions of the CES-D and PRIME-MD-9 in general primary care patients, the GDS in geriatric patients, and the EPDS and PDSS in postpartum patients. This evidence may be remarkably limited compared with comparable evidence in English-speaking primary care populations. Available evidence suggests that the original PRIME-MD-2 may be inaccurate (nonspecifi c) in US Spanishspeaking populations. Our review points to the need for further studies addressing the diagnostic accuracy of ultrabrief, practical depression-screening instruments for use in US Spanish-speaking populations seen in primary care settings.
